Study to Evaluate the Safety and Efficacy of Naldemedine (S-297995) for the Treatment of Opioid-Induced Bowel Dysfunction in Subjects With Chronic Pain
Clinical trial NCT01122030 · COMPLETED
Trial details
- NCT number
- NCT01122030
- Sponsor
- Shionogi
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-05-19
- Primary completion
- 2011-02-23
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.